DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.89, $0.26 better than the analyst estimate of $0.63. Revenue for the quarter came in at $650.2 versus the consensus estimate of $618.36 million.

GUIDANCE:

DexCom sees FY2021 revenue of $2.425-2.45 billion, versus the consensus of $2.4 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.